期刊文献+

端粒酶逆转录酶肽-核酸病毒样颗粒疫苗抗肝癌免疫的初步研究 被引量:1

A preliminary study on anti-liver cancer immunity of the virus-like particulate peptide-nucleic acid vaccine
原文传递
导出
摘要 目的设计人端粒酶逆转录酶(h T E R T)的新型病毒样颗粒疫苗,并研究其抗肝癌的作用。方法以阳离子抗原肽为桥梁,将人粒细胞、巨噬细胞集落刺激因子和h T E R T克隆入真核双表达载体 p T C A E中,再将多肽和核酸疫苗结合于同一疫苗颗粒,转染并鉴定其免疫原性,评价其转染效率,并观察其免疫转基因小鼠后激发特异性细胞毒性T淋巴细胞(CTL)反应的有效性。结果该疫苗可激发特异性 CTL反应,并对肝癌细胞具有特异性杀伤活性。结论成功构建了具有特异性CTL杀伤活性的hTERT肽核酸病毒样颗粒疫苗,为进一步探索其体内抗肝癌免疫作用奠定了基础。 Objectives To construct a novel virus-like particulate peptide-nucleic acid vaccine (VPNV) of human telomerase reverse transcriptase (hTERT), and to study its anti-liver cancer immunity. Methods A cationic antigenic peptide was synthesized and purified, and then human granulocyte macrophage colony stimulating factor (hGM- CSF) and TERT gene were cloned into the eukaryotic expression vector pTCAE. The peptide was combined with the nucleic acid vaccine to make a VPNV, which was transfected into eukaryotic cell COS-7. The inimunogenicity of hGMCSF and hTERT were detected using ELISA and Western blot. The efficacy of VPNV for inducing antigen specific CTL response was determined using the lactate dehydrogenase release method. Results VPNV was verified capable to trigger specific CTL responses and has shown a specific cytolytic activity to liver cancer cell HepG2. Conclusion A VPNV which can stimulate antigen specific CTL response was successfully constructed. This paves the way for our further investigation of anti-liver cancer immunity in mice.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2006年第4期272-276,共5页 Chinese Journal of Hepatology
基金 国家自然科学基金(30400208)
关键词 肝细胞 癌症疫苗 T淋巴细胞 细胞毒性 端粒酶逆转录酶 Carcinoma, hepatocellular Cancer vaccines T-lymphocytes, cytotoxic Human telomerase reverse transcriptase
  • 相关文献

参考文献13

  • 1罗元辉,房殿春,杨仕明,鲁荣,刘为纹.端粒酶活性在原发性肝癌中的表达及临床意义[J].中华肝脏病杂志,1998,6(3):133-135. 被引量:15
  • 2Vonderheide RH.Telomerase as a universal tumor-associated antigen for cancer immunotherapy.Oncogene,2002,21:674-679.
  • 3Berzofsky JA,Terabe M,Oh S,et al.Progress on new vaccine strategies for the immunotherapy and prevention of cancer.J Clin Invest,2004,113:1515-1525.
  • 4Gross DA,Graff-Dubois S,Opolon P,et al.High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.J Clin Invest,2004,113:425-433.
  • 5Chang DZ,Lomazow W,Joy Somberg C,et al.Granulocyte-macrophage colony stimulating factor:an adjuvant for cancer vaccines.Hematology,2004,9:207-215.
  • 6Chow YH,Huang WL,Chi WK,et al.Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.J Virol,1997,71:169-178.
  • 7Liu G,Molas M,Grossmann GA,et al.Biological properties of polyL-lysine-DNA complexes generated by cooperative binding of the polycation.J Biol Chem,2001,276:34379-34387.
  • 8Luo D,Saltzman WM.Synthetic DNA delivery systems.Nat Biotechnol,2000,18:33-37.
  • 9Cho YW,Kim JD,Park K.Polycation gene delivery systems:escape from endosomes to cytosol.J Pharm Pharmacol,2003,55:721-734.
  • 10Sheng KC,Pietersz GA,Wright MD,et al.Dendritic cells:activation and maturation--applications for cancer immunotherapy.Curr Med Chem,2005,12:1783-1800.

共引文献14

同被引文献51

  • 1Shay JW, Bacchetti S. A survey of telomerase activity in human cancer [J]. Eur J Cancer, 1997, 33(5) :787-791.
  • 2Gross DA, Graff-Dubois S, Opolon P, et al. High vaccination efficiency of low-afinity epitopes in antitumor immunotherapy [ J ]. J Clin Invest, 2004, 113(3) : 425-433.
  • 3Chang DZ, Lomazow W, Joy Somberg C, et al. Granulocyte- macrophage colony stimulating factor: an adjuvant for cancer vaccines [ J]. Hematology, 2004, 9(3): 207-215.
  • 4Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in tetrahymena extracts [ J ]. Cell, 1985, 43( 2 Pt 1) : 405-413.
  • 5Hastie ND, Dempster M, Damlop MG, et al. Telomere reduction in human colorectal carcinoma and with ageing [ J . Nature, 1990, 346(6287) : 866-868.
  • 6Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fissio yeast and human [ J ]. Science, 1997, 277(5328): 955-959.
  • 7Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer [ .1 ]. Science, 1994, 266 ( 5193 ) : 2011-2015.
  • 8Tahara H, Yasui W, Tahara E, et al. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections [ J . Oncogene, 1999, 18(8): 1561-1567.
  • 9Sahin E, Depinho RA. Linking functional decline of telomeres, mitochondria and stem cells during ageing [ J ].Nature, 2010, 464(7288) : 520-528.
  • 10Greenberg RA, Chin L, Femino A, et al. Short dysfunctional telomeres impair tumorigenesis in the INK4a( 2/3 ) cancer-prone mouse [J]. Cell, 1999, 97(4) : 515-525.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部